JPRN-jRCT2080222716未知2 期
ONO-6950 Phase 2a study A multicenter, double-blind, randomized parallel-group study in patients with asthma.
ONO PHARMACEUTICAL CO.,LTD.0 个研究点目标入组 100 人开始时间: 2015年1月14日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 64age old（—）
- 性别
- All
入选标准
- •1. patients with ashtma
排除标准
- •1. Has a respiratory disorder other than asthma such as COPD and/or active tuberculosis
- •2. History of serious drug allergy
- •3. If female, are pregnant or breastfeeding
研究者
相似试验
未知
2 期
ONO-4053 Phase 2a studyseasonal allergic rhinitis (Japanese cedar pollinosis)JPRN-jRCT2080222655ONO PHARMACEUTICAL CO.,LTD.200
未知
2 期
ONO-2745 Phase II StudyPostoperative patients requiring sedation during artificial ventilation in intensive care unit.JPRN-jRCT2080221927ONO PHARMACEUTICAL CO.,LTD.90
未知
2 期
ONO-2745 IIb/III StudyPatients undergoing surgery requiring general anesthesiaJPRN-jRCT2080221928ONO PHARMACEUTICAL CO.,LTD.325
未知
2 期
ONO-8025 Phase II StudyCOPDJPRN-jRCT2080221718ONO PHARMACEUTICAL CO.,LTD.26
未知
2 期
A phase 2 multicenter clinical study evaluating the safety and efficacy of Nilotinib in patients with Imatinib- resistant/intolerant CML in chronic phaseChronic myelogenous leukemiaJPRN-UMIN000001927Tokyo STI Study Group50